Crossmark

Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: over a decade of follow-up in the Tehran Lipid and Glucose Study

Crossref DOI link: https://doi.org/10.1186/s12889-022-14126-4

Published Online: 2022-09-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deravi, Niloofar

Moazzeni, Seyyed Saeed

Hasheminia, Mitra

Hizomi Arani, Reyhane

Azizi, Fereidoun

Hadaegh, Farzad
License Information

Text and Data Mining valid from 2022-09-16

Version of Record valid from 2022-09-16
More Information

Article History

Received: 30 October 2021

Accepted: 6 September 2022

First Online: 16 September 2022

Declarations

:

: This study was approved by the Institutional Review Board (IRB) of the Research Institute for Endocrine Sciences (RIES), Shahid Beheshti University of Medical Sciences, and all participants provided written informed consent. All methods were done in accordance with the relevant guidelines and regulations.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below